Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Mindray Rushes To Meet Demand Surge for Patient Monitors Following May Earthquake

This article was originally published in PharmAsia News

Executive Summary

BEIJING - With a spike in orders for patient monitors following China's 7.9 magnitude earthquake, Mindray Medical International has ramped up production to supply hospitals throughout the devastated region

You may also be interested in...



Chinese Mindray Sees Increased International Growth Through U.S. Datascope Acquisition

SHANGHAI - Shenzhen-based Mindray Medical International saw strong international growth through its acquisition of American Datascope's patient monitoring business in May, the company said in a second quarter earnings call Sept. 4

Chinese Mindray Sees Increased International Growth Through U.S. Datascope Acquisition

SHANGHAI - Shenzhen-based Mindray Medical International saw strong international growth through its acquisition of American Datascope's patient monitoring business in May, the company said in a second quarter earnings call Sept. 4

Tianyin Completes Government Commission For Post-quake Medicines, Expects Expanded Revenue Despite Disruption In Operation

BEIJING - Tianyin Pharmaceutical recently completed a special government commission for traditional Chinese medicines and western drugs as part of a massive relief effort following a magnitude 7.9 earthquake that ripped through the western Chinese province of Sichuan in May

UsernamePublicRestriction

Register

MT125590

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel